Exclusive: GSK nears deal to buy Human Genome – sources
NEW YORK/LONDON (Reuters) – GlaxoSmithKline is nearing a deal to acquire Human Genome Sciences for about $2. 8 billion in cash after pursuing the U. S. biotech company for three months, two sources familiar with the situation said on Sunday. The British pharmaceutical giant is expected to raise its offer to around $14 per share from $13 previously, the sources said, declining to be identified because the information was confidential. A deal is expected to be announced before the U. S. stock market opens on Monday, they said. . . .
View full post on Health News Headlines – Yahoo! News
Leave a Reply